Fmoc-N-amido-PEG1-acid CAS NO.1654740-73-4

We have produced this product many years and now got scale production .Purity can reach more than 98%.

The Corporation's main  product are high purity single molecular  PEG series derivatives, hydroxyproline series derivatives, polypeptide long acting drug side chain and its intermediates (including Semaglutide side chain, liraglutide side chain, Degu insulin side chain, long-acting production hormone, etc.), and short peptide drugs modified side chains (semaglutide dipeptide, tetrapeptide).

    Our company is working with innovative pharmaceutical companies to build a platform for research and development of polypeptide long-acting drugs, and is committed to building a systematic and diverse long-acting side chain library, establishing molecular blocks of polypeptide long-acting side chains, and providing various development solutions for customers to develop polypeptide long-acting drugs.

CAS:1654740-73-4

Molecular Weight:355.38

Molecular Formula:C20H21NO5

Appearance:Yellowish liquid

Application:Medical intermediate

Delivery Time:Customized

Package: inside:glass bottle outside: paper drum

Port:Any port in China

Production Capacity:More than 10kg

Purity:≥95%

Storage:Store at 2-8°C

Transportation:CIF by air or DAP by courier, FOB, EX W Etc...

As a production, sales, research and development as one of the manufacturers. At present, the company has 2400 square meters of RESEARCH and development center, 1000 square meters of production workshop. Plan to build 12000 square meters of production base, according to GMP standard quality system management. In recent years, Pukang pharmaceutical has been audited more than ten times by well-known pharmaceutical enterprises at home and abroad, and has been recognized. The main products of the company include high purity single molecule polyethylene glycol derivatives, long-acting drug side chains of polypeptides and their intermediates (including cimerlutide side chains, liraglutide side chains, insulin Degludec side chains, long-acting human growth hormone side chains, etc.), short peptide drug modified side chains (cimerlutide dipeptide, tetraceptides). The company is cooperating with innovation Pharmaceutical company to build a long-term peptide drug research and development platform, committed to building a systematic variety of long-term peptide side chain library, establish long-term peptide side chain molecular blocks, and provide customers with a variety of solutions for the development of long-term peptide drugs. Companies adhering to the "quality first, technology first" concept, to provide the best products and the best service for customers around the world.